Effectiveness and safety of niraparib as neoadjuvant therapy in advanced ovarian cancer with homologous recombination deficiency: NANT study protocol for a prospective, multicenter, exploratory, phase 2, single-arm study (041)

Authors:
  • YYYang Yu
    Yang Yu
  • WZWei Zhang
    Wei Zhang
  • RLRonghua Liu
    Ronghua Liu
  • WSWanying Shan
    Wanying Shan
  • HLHuayi Li
    Huayi Li
  • JLJiahao Liu
    Jiahao Liu
  • BXBairong Xia
    Bairong Xia
  • SHShanyang He
    Shanyang He
  • YXYu Xia
    Yu Xia
  • SWSiyuan Wang
    Siyuan Wang
  • TFTian Fang
    Tian Fang
  • ZWZhi Wang
    Zhi Wang

Abstract
No abstract available